There is a burning need for blockchain in pharma. Today, large pharmaceutical companies are betting on blockchain to help accelerate drug development and discovery, better understand how certain chemicals affect specific demographics, and improve their supply chain, all by securely sharing data in real time.
Leading pharmaceutical companies and life sciences organizations around the globe are moving fast to revolutionize the way they do business. With dramatically increased spending and investment in digital transformation initiatives, these firms are focused on accelerating business growth and efficiency while minimizing costs.
In a collaboration using a neutral zone, organizations do not have access to each other’s data, but will instead have access to insights gathered by pooling their data together with other organizations for analysis by artificial intelligence technology.
